Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA.
Published the 09/12/2022
- Blood Adv
- pmid : 36477770
Epigenome modifications and genomic instability in normal and malignant B cells
Damaj G, Aubrais R, Bouabdallah K, Chartier L, Herbaux C, Banos A, Brice P, Sibon D, Schiano JM, Cluzeau T, Laribi K, LE Calloch R, Bellal M, Delapierre B, Daguindau N, Amorim S, Agbetiafa K, Chauchet A, Besson C, Durot E, Bonnet C, Fouillet L, Bijou F, Tournilhac O, Gaulard P, Parrens MC
Published the 17/11/2022
- Nat Commun
- pmid : 36396648
Meiosis and recombination
Nore A., Juarez-Martinez A. B., Clement J., Brun C., Diagouraga B., Laroussi H., Grey C., Bourbon H. M., Kadlec J., Robert T., de Massy B.
more
Published the 05/11/2022
- International Journal of Molecular Sciences
Gene regulation
Giuseppa Grasso and Rosemary Kiernan
more
Targeting the β(2) -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
Published the 18/10/2022
- J Pathol
- pmid : 36245401
Epigenome modifications and genomic instability in normal and malignant B cells
Satilmis H, Verheye E, Vlummens P, Oudaert I, Vandewalle N, Fan R, Knight JM, De Beule N, Ates G, Massie A, Moreaux J, Maes A, De Bruyne E, Vanderkerken K, Menu E, Sloan EK, De Veirman K
miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study
Published the 17/10/2022
- Front Immunol
- pmid : 36325355
Epigenome modifications and genomic instability in normal and malignant B cells
Isabelle Duroux-Richard, Anne-Laure Gagez, Elina Alaterre, Rémi Letestu, Olfa Khalifa, Christian Jorgensen, Stéphane Leprêtre, Emmanuelle Tchernonog, Jérôme Moreaux, Guillaume Cartron, Florence Apparailly
Repression and 3D-restructuring resolves regulatory conflicts in evolutionarily rearranged genomes.
Published the 01/10/2022
- Cell
Chromatin and cell biology
Ringel AR, Szabo Q, Chiariello AM, Chudzik K, Schöpflin R, Rothe P, Mattei AL, Zehnder T, Harnett D, Laupert V, Bianco S, Hetzel S, Glaser J, Phan MHQ, Schindler M, Ibrahim DM, Paliou C, Esposito A, Prada-Medina CA, Haas SA, Giere P, Vingron M, Wittler L, Meissner A, Nicodemi M, Cavalli G, Bantignies F, Mundlos S, Robson MI
Published the 26/09/2022
- Current Opinion in Immunology
- pmid : 36174411
van der Horst D, Carter-Timofte ME, van Grevenynghe J, Laguette N, Dinkova-Kostova AT, Olagnier D
more
NF90 interacts with components of RISC and modulates association of Ago2 with mRNA.
Published the 02/09/2022
- BMC Biol
- pmid : 36050755
Gene regulation
Grasso G*, Akkawi C*, Franckhauser C, Nait-Saidi R, Bello M, Barbier J, Kiernan R
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.
Published the 02/09/2022
- Eur J Haematol
- pmid : 36048142
Epigenome modifications and genomic instability in normal and malignant B cells
Daniel A, Ghez D, Ravaiau C, Cavalieri D, Tournilhac O, Herbaux C, Roriz M, Wemeau M, Guillet S, Bossard JB, Hélène D, Kaphan E, Caroline R, Florence L, Pierache A, Michel M, Godeau B, Terriou L
Alternative pathways driven by STING: From innate Immunity to lipid metabolism.
Published the 01/09/2022
- Cytokine & Growth Factor Reviews
- pmid : 36085258
Vila IK, Guha S, Kalucka J, Olagnier D, Laguette N.